Caveolin-1 and -2 and their relationship to cerebral amyloid angiopathy in Alzheimer's disease

Neuropathology and Applied Neurobiology

Volumn 33, Issue 3, 2007, Pages 317-327

  Van Helmond, Z K ^a,b   Miners, J S ^a   Bednall, E ^a   Chalmers, K A ^a   Zhang, Y ^a   Wilcock, G K ^a   Love, S ^a   Kehoe, P G ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b FRENCHAY HOSPITAL   (United Kingdom)

Author keywords

Alzheimer's disease; Amyloid peptide; Caveolin 1; Caveolin 2; Cerebral amyloid angiopathy; Tunica media

Indexed keywords

ACTIN; ALPHA SECRETASE; AMYLOID BETA PROTEIN; APOENZYME; CAVEOLIN 1; CAVEOLIN 2;

ADULT; AGED; ALZHEIMER DISEASE; ANTIBODY LABELING; ARTICLE; BIOACCUMULATION; BRAIN BLOOD VESSEL; BRAIN WEIGHT; CADAVER; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FRONTAL CORTEX; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PARIETAL LOBE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SMOOTH MUSCLE; TEMPORAL LOBE; TUNICA MEDIA; VASCULAR AMYLOIDOSIS; VASCULAR ENDOTHELIUM; WHITE MATTER;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BLOOD VESSELS; BRAIN; CAVEOLIN 1; CAVEOLIN 2; CEREBRAL AMYLOID ANGIOPATHY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED;

EID: 34247882921     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2006.00815.x     Document Type: Article

References (44)

1. Small DH. The role of the amyloid protein precursor (APP) in Alzheimer's disease: does the normal function of APP explain the topography of neurodegeneration? Neurochem Res 1998 23 : 795 6
2. Neve RL. A new wrestler in the battle between alpha- and beta-secretases for cleavage of APP. Trends Neurosci 2003 26 : 461 3
3. Storey E, Cappai R. The amyloid precursor protein of Alzheimer's disease and the Aβ peptide. Neuropathol Appl Neurobiol 1999 25 : 81 97
4. Couet J, Belanger MM, Roussel E, Drolet MC. Cell biology of caveolae and caveolin. Adv Drug Deliv Rev 2001 49 : 223 35
5. Schlegel A, Volonte D, Engelman JA, Galbiati F, Mehta P, Zhang XL, Scherer PE, Lisanti MP. Crowded little caves: structure and function of caveolae. Cell Signal 1998 10 : 457 63
6. Stan RV. Structure and function of endothelial caveolae. Microsc Res Tech 2002 57 : 350 64
7. Virgintino D, Robertson D, Errede M, Benagiano V, Tauer U, Roncali L, Bertossi M. Expression of caveolin-1 in human brain microvessels. Neuroscience 2002 115 : 145 52
8. Simons K, Ikonen E. Functional rafts in cell membranes. Nature 1997 387 : 569 72
9. Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2000 1 : 31 9
10. Okamoto T, Schlegel A, Scherer PE, Lisanti MP. Caveolins, a family of scaffolding proteins for organizing 'preassembled signaling complexes' at the plasma membrane. J Biol Chem 1998 273 : 5419 22
11. Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR, Anderson RG. Caveolin, a protein component of caveolae membrane coats. Cell 1992 68 : 673 82
12. Scherer PE, Okamoto T, Chun M, Nishimoto I, Lodish HF, Lisanti MP. Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. Proc Natl Acad Sci USA 1996 93 : 131 5
13. Tang Z, Scherer PE, Okamoto T, Song K, Chu C, Kohtz DS, Nishimoto I, Lodish HF, Lisanti MP. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem 1996 271 : 2255 61
14. Scherer PE, Lewis RY, Volonte D, Engelman JA, Galbiati F, Couet J, Kohtz DS, van Donselaar E, Peters P, Lisanti MP. Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J Biol Chem 1997 272 : 29337 46
15. Ikezu T, Ueda H, Trapp BD, Nishiyama K, Sha JF, Volonte D, Galbiati F, Byrd AL, Bassell G, Serizawa H, Lane WS, Lisanti MP, Okamoto T. Affinity-purification and characterization of caveolins from the brain: differential expression of caveolin-1, -2, and -3 in brain endothelial and astroglial cell types. Brain Res 1998 804 : 177 92
16. Parolini I, Sargiacomo M, Galbiati F, Rizzo G, Grignani F, Engelman JA, Okamoto T, Ikezu T, Scherer PE, Mora R, Rodriguez-Boulan E, Peschle C, Lisanti MP. Expression of caveolin-1 is required for the transport of caveolin-2 to the plasma membrane. Retention of caveolin-2 at the level of the golgi complex. J Biol Chem 1999 274 : 25718 25
17. Mora R, Bonilha VL, Marmorstein A, Scherer PE, Brown D, Lisanti MP, Rodriguez-Boulan E. Caveolin-2 localizes to the golgi complex but redistributes to plasma membrane, caveolae, and rafts when co-expressed with caveolin-1. J Biol Chem 1999 274 : 25708 17
18. Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaluso F, Russell RG, Li M, Pestell RG, Di Vizio D, Hou H Jr, Kneitz B, Lagaud G, Christ GJ, Edelmann W, Lisanti MP. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 2001 276 : 38121 38
19. Fielding CJ, Fielding PE. Cholesterol and caveolae: structural and functional relationships. Biochim Biophys Acta 2000 1529 : 210 22
20. Engelman JA, Zhang X, Galbiati F, Volonte D, Sotgia F, Pestell RG, Minetti C, Scherer PE, Okamoto T, Lisanti MP. Molecular genetics of the caveolin gene family: implications for human cancers, diabetes, Alzheimer disease,and muscular dystrophy. Am J Hum Genet 1998 63 : 1578 87
21. Kojro E, Gimpl G, Lammich S, Marz W, Fahrenholz F. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha-secretase ADAM 10. Proc Natl Acad Sci USA 2001 98 : 5815 20
22. Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci USA 1998 95 : 6460 4
23. Abad-Rodriguez J, Ledesma MD, Craessaerts K, Perga S, Medina M, Delacourte A, Dingwall C, De Strooper B, Dotti CG. Neuronal membrane cholesterol loss enhances amyloid peptide generation. J Cell Biol 2004 167 : 953 60
24. Bodovitz S, Klein WL. Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein. J Biol Chem 1996 271 : 4436 40
25. Ehehalt R, Keller P, Haass C, Thiele C, Simons K. Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J Cell Biol 2003 160 : 113 23
26. Hooper NM. Roles of proteolysis and lipid rafts in the processing of the amyloid precursor protein and prion protein. Biochem Soc Trans 2005 33 : 335 8
27. Lee SJ, Liyanage U, Bickel PE, Xia W, Lansbury PT Jr, Kosik KS. A detergent-insoluble membrane compartment contains A beta in vivo. Nat Med 1998 4 : 730 4
28. Puglielli L, Konopka G, Pack-Chung E, Ingano LA, Berezovska O, Hyman BT, Chang TY, Tanzi RE, Kovacs DM, Acyl-coenzyme A. cholesterol acyltransferase modulates the generation of the amyloid beta-peptide. Nat Cell Biol 2001 3 : 905 12
29. Urano Y, Hayashi I, Isoo N, Reid PC, Shibasaki Y, Noguchi N, Tomita T, Iwatsubo T, Hamakubo T, Kodama T. Association of active gamma-secretase complex with lipid rafts. J Lipid Res 2005 46 : 904 12
30. Vetrivel KS, Cheng H, Lin W, Sakurai T, Li T, Nukina N, Wong PC, Xu H, Thinakaran G. Association of gamma-secretase with lipid rafts in post-Golgi and endosome membranes. J Biol Chem 2004 279 : 44945 54
31. Kaether C, Haass C. A lipid boundary separates APP and secretases and limits amyloid beta-peptide generation. J Cell Biol 2004 167 : 809 12
32. Wolozin B. A fluid connection: cholesterol and Abeta. Proc Natl Acad Sci USA 2001 98 : 5371 3
33. Ikezu T, Trapp BD, Song KS, Schlegel A, Lisanti MP, Okamoto T. Caveolae, plasma membrane microdomains for alpha-secretase-mediated processing of the amyloid precursor protein. J Biol Chem 1998 273 : 10485 95
34. Gaudreault SB, Dea D, Poirier J. Increased caveolin-1 expression in Alzheimer's disease brain. Neurobiol Aging 2004 25 : 753 9
35. Wu Z, Guo H, Chow N, Sallstrom J, Bell RD, Deane R, Brooks AI, Kanagala S, Rubio A, Sagare A, Liu D, Li F, Armstrong D, Gasiewicz T, Zidovetzki R, Song X, Hofman F, Zlokovic BV. Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease. Nat Med 2005 11 : 959 65
36. Braak H, Braak E. Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1991 1 : 213 16
37. Chalmers K, Wilcock GK, Love S. APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein. Neuropathol Appl Neurobiol 2003 29 : 231 8
38. Love S, Nicoll JA, Hughes A, Wilcock GK. APOE and cerebral amyloid angiopathy in the elderly. Neuroreport 2003 14 : 1535 6
39. Wenham PR, Price WH, Blandell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991 337 : 1158 9
40. Scherer PE, Tang Z, Chun M, Sargiacomo M, Lodish HF, Lisanti MP. Caveolin isoforms differ in their N-terminal protein sequence and subcellular distribution. Identification and epitope mapping of an isoform-specific monoclonal antibody probe. J Biol Chem 1995 270 : 16395 401
41. Cho KA, Park SC. Caveolin-1 as a prime modulator of aging: a new modality for phenotypic restoration? Mech Ageing Dev 2005 126 : 105 10
42. Rensink AA, de Waal RM, Kremer B, Verbeek MM. Pathogenesis of cerebral amyloid angiopathy. Brain Res Brain Res Rev 2003 43 : 207 23
43. Kawai M, Kalaria RN, Cras P, Siedlak SL, Velasco ME, Shelton ER, Chan HW, Greenberg BD, Perry G. Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease. Brain Res 1993 623 : 142 6
44. Miners JS, van Helmond Z, Chalmers K, Wilcock G, Love S, Kehoe PG. Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy. J Neuropathol Exp Neurol 2006 65 : 1012 21